Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Beta Glucosylceramide for Treatment of Non Alcoholic Steatohepatitis

NCT02126306 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.

NCT NCT02126306
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02126306 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Beta Glucosylceramide for Treatment of Non Alcoholic Steatohepatitis
Lead sponsor
Hadassah Medical Organization
Phase
Phase 1/2
Overall status
Completed
Start date
January 31, 2006
Completion date
December 31, 2010
Enrollment
23 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

compliance behavior